Stockreport

Visionary Holdings (Nasdaq: GV) Secures Global License for Breakthrough Stem Cell Technology Aimed at Diabetes Remission and Potential Complete Cure in a USD 150 Billion Global Market

Visionary Holdings Inc. - Common Shares  (GV) 
NASDAQ:AMEX Investor Relations: ir.goldfieldcorp.com
PDF TORONTO, Oct. 13, 2025 /PRNewswire/ -- Visionary Holdings Inc. ("GV" or the "Company"), a technology-driven multinational enterprise li [Read more]